102 results on '"Thybaud, Véronique"'
Search Results
2. Strategies in case of positive in vivo results in genotoxicity testing
3. Compilation and use of genetic toxicity historical control data
4. Cytosine arabinoside, vinblastine, 5-fluorouracil and 2-aminoanthracene testing in the in vitro micronucleus assay with L5178Y mouse lymphoma cells at Sanofi Aventis, with different cytotoxicity measurements, in support of the draft OECD Test Guideline on In Vitro Mammalian Cell Micronucleus Test
5. Collaborative study on fifteen compounds in the rat-liver Comet assay integrated into 2- and 4-week repeat-dose studies
6. Opportunities to integrate new approaches in genetic toxicology: An ILSI-HESI workshop report
7. Fourth International Workgroup on Genotoxicity testing: Results of the in vivo Comet assay workgroup
8. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop
9. In Vivo Genotoxicity Assays
10. SFTG international collaborative study on in vitro micronucleus test: III. Using CHO cells
11. SFTG international collaborative study on in vitro micronucleus test: I. General conditions and overall conclusions of the study
12. SFTG international collaborative study on in vitro micronucleus test: IV. Using CHL cells
13. SFTG international collaborative study on in vitro micronucleus test: II. Using human lymphocytes
14. SFTG international collaborative study on in vitro micronucleus test: V. Using L5178Y cells
15. Need and potential value of the Pig-a in vivo mutation assay—A hesi perspective
16. Follow-up actions from positive results of in vitro genetic toxicity testing
17. New and emerging technologies for genetic toxicity testing
18. Strategies for the follow-up of positive results in the in vitro genotoxicity assays—An international collaborative initiative
19. Application of the adverse outcome pathway framework to genotoxic modes of action
20. Application of Toxicogenomics to Genetic Toxicology Risk Assessment
21. Application of the adverse outcome pathway framework to genotoxic modes of action.
22. Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay
23. Opportunities to integrate new approaches in genetic toxicology: An ILSI-HESI workshop report
24. IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk
25. IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure–response relationships and points of departure (PoDs)
26. Opportunities to integrate new approaches in genetic toxicology: An ILSI-HESI workshop report
27. Performance and data interpretation of the in vivo comet assay in pharmaceutical industry: EFPIA survey results
28. Need and potential value of the Pig-ain vivo mutation assay-A hesi perspective
29. Follow-up actions from positive results of in vitro genetic toxicity testing
30. New and emerging technologies for genetic toxicity testing
31. Strategies for the follow‐up of positive results in the in vitro genotoxicity assays—An international collaborative initiative
32. Relevance and follow-up of positive results in in vitro genetic toxicity assays: An ILSI-HESI initiative
33. Impact of positive results from in vitro genotoxicity
34. Laboratory variability does not preclude identification of biological functions impacted by hydroxyurea
35. The autoradiographic test for unscheduled DNA synthesis: a sensitive assay for the detection of DNA repair in the HepG2 cell line
36. In vivo transgenic mutation assays
37. Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of Muta™Mice treated with 5,9-dimethyldibenzo[c,g]carbazole
38. Kinetics of induction of DNA damage and lacZ gene mutations in stomach mucosa of mice treated with β‐propiolactone and N‐methyl‐N′‐nitro‐N‐nitrosoguanidine, using single‐cell gel electrophoresis and MutaTMMouse models
39. Comparative mutagenicity of 7H-dibenzo[c,g]carbazole and two derivatives in Muta™Mouse liver and skin
40. P XV.17 Kinetics of detection of β-proplolactone and N-methyl-N′-nitro-N-nitrosoguanidine genotasic effects in mouse gastric mucosa using single gel cell electrophoresis assay and Muta™″ mouse assay
41. P XV.15 Tissue-specific mutagenicity of 7H-dibenzo[c,g]carbazole and two derivatives in Muta™″ Mouse following topical application
42. O XIX B.3 How new in vivo assays will help in the assessment of genotoxicity risk
43. P XV.13 Role of DNA-adduct formation and cell proliferation in the induction of gene mutations by 5,9-dimethyl-dibenzocarbazole in Muta™″ Mouse liver
44. Effect of ethylnitrosourea and methyl methanesulfonate on mutation frequency in Muta™Mouse germ cells (seminiferous tubule cells and epididymis spermatozoa)
45. Sources of variability in data from a positive selection lacZ transgenic mouse mutation assay: An interlaboratory study
46. Kinetics of DNA adduct formation and removal in mouse hepatocytes following in vivo exposure to 5,9-dimethyldibenzo[c,g]carbazole.
47. RARE EVENTS DETECTION: A COMPARATIVE STUDY BETWEEN FLOW CYTOMETRY AND CLONING FOR DETECTION OF HPRT MUTANTS INDUCED BY ETHYLMETHANESULFONATE IN CHO-K1 CELLS
48. Kinetics of induction of DNA damage and lacZ gene mutations in stomach mucosa of mice treated with β-propiolactone and N-methyl- N′-nitro- N-nitrosoguanidine, using single-cell gel electrophoresis and MutaTMMouse models.
49. Effect of mitogenic or regenerative cell proliferation on lacz mutant frequency in the liver of Muta™Mice treated with 5,9-dimethyldibenzo[c,g]carbazole.
50. Kinetics of induction of DNA damage and lacZgene mutations in stomach mucosa of mice treated with β‐propiolactone and N‐methyl‐N′‐nitro‐N‐nitrosoguanidine, using single‐cell gel electrophoresis and MutaTMMouse models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.